Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tom Cohen
AddedMar 31, 2024
UpdatedMay 31, 2026
Tom Cohen

Tom Cohen

Founder, Nanopore Diagnostics

CrunchbaseLinkedIn

Tom Cohen's Career

Nanopore Diagnostics
Nanopore Diagnostics

St. Louis, MO, US

Founder
Solis Agrosciences
Solis Agrosciences

St. Louis, MO, US

Co-Founder & CEO· C-Suite · Management
Panome Bio
Panome Bio

St. Louis, MO, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tom Cohen's Career

Nanopore Diagnostics
Nanopore Diagnostics
$825k12012St. Louis, MO, US
Founder

Similar to Nanopore Diagnostics

NAT DiagnosticsNAT DiagnosticsSan Diego, CA, USDiagnostics, Medical Devicesest. 2014NAT DiagnosticsSan Diego, CA, US · est. 2014

NAT Diagnostics: Providing rapid, accurate point-of-care infectious disease testing since 2014.

Seed · $4.4M30
Prompt DiagnosticsPrompt DiagnosticsBaltimore, MD, USDiagnostic TestsPrompt DiagnosticsBaltimore, MD, US

Prompt Diagnostics: Rapid, affordable, and precise biotech firm for easy-to-use diagnostic testing.

Pre-Seed · $600k2
Test DiagnosticsTest DiagnosticsNew York City, NY, USDiagnostics, Medical DevicesTest DiagnosticsNew York City, NY, US

NYC-based Test Diagnostics develops Point-of-Care diagnostic technology.

Seed · $334k2
BioAmp diagnosticsBioAmp diagnosticsSan Francisco, CA, USDiagnostics, Medical Devicesest. 2017BioAmp diagnosticsSan Francisco, CA, US · est. 2017

BioAmp: Developing precision diagnostics to combat antibiotic resistance, empowering physicians.

Angel · $225k5
Solis Agrosciences
Solis Agrosciences
Seed$3.1M162021St. Louis, MO, US
Co-Founder & CEO· C-Suite · Management

Leadership at Solis Agrosciences

Mary FernandesMary FernandesCo-Founder
Brian SalmoBrian SalmoBoard Member
Charlie BoltenCharlie BoltenCo-Founder

Similar to Solis Agrosciences

Botanisol AnalyticsBotanisol AnalyticsPhoenix, AZ, USBiotech Servicesest. 2018Botanisol AnalyticsPhoenix, AZ, US · est. 2018

Botanisol Analytics, Inc.: A US-based agricultural biotech firm innovating crop molecular compositions.

Series A · $120k30
NitrogenicsNitrogenicsSt. Louis, MO, USAnalysis, Researchest. 2015NitrogenicsSt. Louis, MO, US · est. 2015

Plant biotech research analysis for nitrogen fixation in crops. Enabling plants to absorb nitrogen from the atmosphere.

Seed · $175k50
TraitologyTraitologyRaleigh, NC, USCrop Improvementest. 2022TraitologyRaleigh, NC, US · est. 2022

Traitology: A digital biology firm innovating novel traits in soybean and key global crops.

Seed · $25M30
PlastomicsPlastomicsSt. Louis, MO, USCrop Enhancementest. 2017PlastomicsSt. Louis, MO, US · est. 2017

Plastomics Inc., a US biotech startup, enhances crop performance through chloroplast genetic engineering.

Series A · $9.4M29
Panome Bio
Panome Bio
Series A$6M132022St. Louis, MO, US
Co-Founder

Leadership at Panome Bio

Gary PattiGary PattiCo-Founder
Edward WeinsteinEdward WeinsteinCo-Founder

Similar to Panome Bio

MetabolonMetabolonDurham, NC, USBiomarkers, Diagnosticsest. 2000MetabolonDurham, NC, US · est. 2000

Metabolon, based in Durham, US, leads in metabolomics for biomarker discovery, diagnostics & precision medicine.

Public · $199.7M302
BiomiicBiomiicBoston, MA, USMicrobiome Sequencingest. 2015BiomiicBoston, MA, US · est. 2015

Biomiic: A rapid, precise microbiome sequencing service using high-throughput metagenomics for biomarker discovery.

Angel · $100k5
SapientSapientSan Diego, CA, USBiomarkers, Drug Discoveryest. 2020SapientSan Diego, CA, US · est. 2020

Sapient accelerates biomarker discovery with advanced mass spectrometry and biocomputational analysis.

Series A · $13.8M125
Phenomix SciencesPhenomix SciencesRochester, MN, USBiotechest. 2017Phenomix SciencesRochester, MN, US · est. 2017

Phenomix Sciences: A biotech firm excelling in life science, metabolomics, and genomics.

Pre-Seed · $3.2M5

People Similar to Tom Cohen

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoThomas CooperThomas CooperCo-Founder · PantriMeir AntarMeir AntarCo-Founder · PanoraysKen RosenfeldKen RosenfeldChief Operating Officer · Ognomy SleepVince CavinVince CavinCo-Founder · Perspective